Company Overview of Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. operates as a biopharmaceutical company that develops antibody therapeutics for the treatment of life-threatening infectious disease. The company develops Anthim, a humanized and deimmunized monoclonal antibody that targets the protective antigen of B. anthracis and neutralizes the lethal effects of anthrax toxins. Elusys Therapeutics, Inc. was formerly known as ErythroMed, Inc. The company was founded in 1998 and is based in Pine Brook, New Jersey.
25 Riverside Drive
Pine Brook, NJ 07058
Founded in 1998
Key Executives for Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Diffinity Genomics, Inc.||United States|
|APT Therapeutics, Inc.||United States|
|Osprey Pharmaceuticals USA, Inc.||United States|
|Endacea, Inc.||United States|
|Akkadix Genetics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Miami, FL | MedtronicPosted: Feb 01
- San Mateo, CA |Posted: Apr 05
- Kansas City, MO | SkillsniperPosted: Apr 14
- San Francisco, CA | Anacor PharmaceuticalsPosted: Feb 23
Sponsored Financial Commentaries
To contact Elusys Therapeutics, Inc., please visit www.elusys.com. Company data is provided by Capital IQ. Please use this form to report any data issues.